查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2019485

外泌體技術全球市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Exosome Technologies Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 164 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計外泌體技術市場將從 2025 年的 2.3396 億美元成長到 2034 年的 17.633 億美元，2026 年至 2034 年的複合年成長率為 25.16%。

全球外泌體技術市場正經歷快速成長，這主要得益於細胞間通訊研究的不斷深入和先進治療應用的日益普及。外吐小體在診斷、藥物傳遞和再生醫學中發揮著至關重要的作用，使其在生物醫學研究中具有極高的價值。慢性疾病的日益普遍以及對創新治療方法的需求不斷成長，正在推動市場擴張。此外，分子生物學和生物技術的進步也為基於外吐小體的技術發展提供了支持。

關鍵促進因素包括研發投入的增加和對精準醫療日益成長的興趣。外泌體技術因其在標靶藥物傳遞和非侵入性診斷方面的潛在優勢，正吸引醫療保健領域的廣泛關注。學術機構與生技公司之間的合作正在加速創新。此外，分離和表徵技術的進步也提高了基於外泌體的應用的效率和可靠性。

隨著研究不斷發現新的應用，外泌體技術市場預計將迎來顯著成長。標準化方案和法規結構的發展將促進商業化進程。臨床診斷和治療領域應用的日益廣泛有望進一步推動市場擴張。在新興市場，醫療保健投資的成長以及對先進生物醫學技術日益濃厚的興趣預計將創造新的機會。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章：全球外泌體技術市場：按外泌體類型分類

  • 市場分析、洞察與預測
  • 裝載貨物
  • 非貨物

第5章：全球外泌體技術市場：依細胞來源分類

  • 市場分析、洞察與預測
  • HEK293細胞
  • MSCs
  • 血小板
  • 紅血球
  • 自然殺手細胞
  • 其他

第6章 全球外泌體技術市場：依應用分類

  • 市場分析、洞察與預測
  • 治療
  • 診斷

第7章 全球外泌體技術市場：依最終用戶分類

  • 市場分析、洞察與預測
  • 醫療保健提供者
  • 製藥和生物技術公司
  • 其他

第8章 全球外泌體技術市場：按地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第9章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第10章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Aegle Therapeutics
    • Aruna Bio Inc
    • Bio-Techne Corporation
    • Carmine Therapeutics Inc
    • Codiak BioSciences Inc
    • Creative Biolabs
    • Danaher Corporation（Beckman Coulter Inc.）
    • Fujifilm Holdings Corporation
    • NOVADIP Biosciences SA
    • OmniSpirant Limited
    • Thermo Fisher Scientific Inc
簡介目錄
Product Code: VMR11215742

The Exosome Technologies Market size is expected to reach USD 1763.30 Million in 2034 from USD 233.96 Million (2025) growing at a CAGR of 25.16% during 2026-2034.

The global exosome technologies market is experiencing rapid growth due to increasing research in cell-to-cell communication and advanced therapeutic applications. Exosomes play a crucial role in diagnostics, drug delivery, and regenerative medicine, making them highly valuable in biomedical research. The rising prevalence of chronic diseases and the growing demand for innovative treatment approaches are driving market expansion. Additionally, advancements in molecular biology and biotechnology are supporting the development of exosome-based technologies.

Key drivers include increasing investments in research and development and the growing focus on precision medicine. Exosome technologies offer potential advantages in targeted drug delivery and non-invasive diagnostics, which are attracting significant attention from the healthcare sector. Collaborations between academic institutions and biotechnology companies are accelerating innovation. Furthermore, improvements in isolation and characterization techniques are enhancing the efficiency and reliability of exosome-based applications.

In the future, the exosome technologies market is expected to witness substantial growth as research continues to uncover new applications. The development of standardized protocols and regulatory frameworks will support commercialization. Increasing adoption in clinical diagnostics and therapeutics will further drive market expansion. Emerging markets are anticipated to offer new opportunities due to rising healthcare investments and growing interest in advanced biomedical technologies.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Exosome Type

  • Loaded Cargos
  • Non-cargo

By Cell Source

  • HEK293 Cells
  • MSCs
  • Platelets
  • Erythrocytes
  • Natural Killer Cells
  • Other

By Application

  • Therapeutics
  • Diagnostics

By End-user

  • Health Care Providers
  • Pharmaceutical & Biotechnology Companies
  • Other

COMPANIES PROFILED

  • Aegle Therapeutics, Aruna Bio Inc, BioTechne Corporation, Carmine Therapeutics Inc, Codiak BioSciences Inc, Creative Biolabs, Danaher Corporation Beckman Coulter Inc, Fujifilm Holdings Corporation, NOVADIP Biosciences SA, OmniSpirant Limited, Thermo Fisher Scientific Inc
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL EXOSOME TECHNOLOGIES MARKET: BY EXOSOME TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Exosome Type
  • 4.2. Loaded Cargos Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Non-cargo Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL EXOSOME TECHNOLOGIES MARKET: BY CELL SOURCE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Cell Source
  • 5.2. HEK293 Cells Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. MSCs Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Platelets Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Erythrocytes Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.6. Natural Killer Cells Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.7. Other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL EXOSOME TECHNOLOGIES MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Application
  • 6.2. Therapeutics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL EXOSOME TECHNOLOGIES MARKET: BY END-USER 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast End-user
  • 7.2. Health Care Providers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL EXOSOME TECHNOLOGIES MARKET: BY REGION 2022-2034 (USD MN)

  • 8.1. Regional Outlook
  • 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.2.1 By Exosome Type
    • 8.2.2 By Cell Source
    • 8.2.3 By Application
    • 8.2.4 By End-user
    • 8.2.5 United States
    • 8.2.6 Canada
    • 8.2.7 Mexico
  • 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.3.1 By Exosome Type
    • 8.3.2 By Cell Source
    • 8.3.3 By Application
    • 8.3.4 By End-user
    • 8.3.5 United Kingdom
    • 8.3.6 France
    • 8.3.7 Germany
    • 8.3.8 Italy
    • 8.3.9 Russia
    • 8.3.10 Rest Of Europe
  • 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.4.1 By Exosome Type
    • 8.4.2 By Cell Source
    • 8.4.3 By Application
    • 8.4.4 By End-user
    • 8.4.5 India
    • 8.4.6 Japan
    • 8.4.7 South Korea
    • 8.4.8 Australia
    • 8.4.9 South East Asia
    • 8.4.10 Rest Of Asia Pacific
  • 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.5.1 By Exosome Type
    • 8.5.2 By Cell Source
    • 8.5.3 By Application
    • 8.5.4 By End-user
    • 8.5.5 Brazil
    • 8.5.6 Argentina
    • 8.5.7 Peru
    • 8.5.8 Chile
    • 8.5.9 Rest of Latin America
  • 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.6.1 By Exosome Type
    • 8.6.2 By Cell Source
    • 8.6.3 By Application
    • 8.6.4 By End-user
    • 8.6.5 Saudi Arabia
    • 8.6.6 UAE
    • 8.6.7 Israel
    • 8.6.8 South Africa
    • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

  • 9.1. Recent Developments
  • 9.2. Company Categorization
  • 9.3. Supply Chain & Channel Partners (based on availability)
  • 9.4. Market Share & Positioning Analysis (based on availability)
  • 9.5. Vendor Landscape (based on availability)
  • 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL EXOSOME TECHNOLOGIES INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Company Profiles
    • 10.2.1 Aegle Therapeutics
    • 10.2.2 Aruna Bio Inc
    • 10.2.3 Bio-Techne Corporation
    • 10.2.4 Carmine Therapeutics Inc
    • 10.2.5 Codiak BioSciences Inc
    • 10.2.6 Creative Biolabs
    • 10.2.7 Danaher Corporation (Beckman Coulter Inc.)
    • 10.2.8 Fujifilm Holdings Corporation
    • 10.2.9 NOVADIP Biosciences S.A
    • 10.2.10 OmniSpirant Limited
    • 10.2.11 Thermo Fisher Scientific Inc